Lopressor injection: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
mNo edit summary
No edit summary
Line 1: Line 1:
__NOEDITSECTION____NOTOC__
__NOEDITSECTION____NOTOC__
{{{{BASEPAGENAME}} }}
{{Lopressor injection}}
<div style="width: 80%">
__NOTOC__
{{CMG}}
{{CMG}}


'''''For information about metoprolol, click [[metoprolol|here]].'''''
'''''For information about metoprolol, click [[Metoprolol|here]].'''''


==[[Drug project disclaimer|Disclaimer]]==
==Disclaimer==


==[[{{BASEPAGENAME}}/black box warning|{{fontcolor|#FF0000|Black Box Warning}}]]==
(Disclaimer here)
 
==<span style="color:#FF0000; background:#000000;">Black Box Warning</span>==
 
FDA Package Insert for '''{{PAGENAME}}''' contains no information regarding ''Black Box Warning''.


==Overview==
==Overview==


{{BASEPAGENAME}} is a anti-anginal, antiarrhythmic, beta-adrenergic blocker drug that is FDA approved for the treatment of [[acute myocardial infarction]], [[angina]], and [[hypertension]]. There is a Black Box Warning for this drug as shown <span style="background:#000000;">'''[[{{BASEPAGENAME}}/black box warning|{{fontcolor|#FF0000|here}}]]'''</span>. Common adverse reactions include [[bradyarrhythmia]], [[heart block]], [[heart failure]], [[hypotension]], [[pruritus]], [[rash]], [[constipation]], [[diarrhea]], [[indigestion]], [[nausea]], [[dizziness]], [[fatigue]], [[headache]], [[depression]], [[dyspnea]], and [[wheezing]].
{{PAGENAME}} is a _______ drug that is FDA approved for the treatment of _______. There is a Black Box Warning for this drug as shown <span style="background:#000000;">'''[[{{PAGENAME}}#Black Box Warning|{{fontcolor|#FF0000|here}}]]'''</span>. Common adverse reactions include _______.
 
==Adult Indications and Dosage==
 
===FDA-Labeled Indications and Dosage (Adult)===
 
=====Condition 1=====
 
* Dosing Information
 
:: (Dosage)
 
=====Condition 2=====
 
* Dosing Information
 
:: (Dosage)
 
===Off-Label Use and Dosage (Adult)===
 
====Guideline-Supported Use====
 
=====Condition 1=====
 
* Developed by: (Organisation)
 
* Class of Recommendation: (Class) (Link)
 
* Strength of Evidence: (Category A/B/C) (Link)
 
* Dosing Information
 
:: (Dosage)
 
=====Condition 2=====
 
* Developed by: (Organisation)
 
* Class of Recommendation: (Class) (Link)
 
* Strength of Evidence: (Category A/B/C) (Link)
 
* Dosing Information
 
:: (Dosage)
 
====Non–Guideline-Supported Use====
 
=====Condition 1=====
 
* Dosing Information
 
:: (Dosage)
 
=====Condition 2=====
 
* Dosing Information
 
:: (Dosage)
 
=====Condition 3=====
 
* Dosing Information
 
:: (Dosage)
 
==Pediatric Indications and Dosage==
 
===FDA-Labeled Indications and Dosage (Pediatric)===
 
=====Condition 1=====
 
* Dosing Information
 
:: (Dosage)
 
=====Condition 2=====
 
* Dosing Information
 
:: (Dosage)
 
===Off-Label Use and Dosage (Pediatric)===
 
====Guideline-Supported Use====
 
=====Condition 1=====
 
* Developed by: (Organisation)
 
* Class of Recommendation: (Class) (Link)
 
* Strength of Evidence: (Category A/B/C) (Link)
 
* Dosing Information
 
:: (Dosage)
 
=====Condition 2=====
 
* Developed by: (Organisation)
 
* Class of Recommendation: (Class) (Link)
 
* Strength of Evidence: (Category A/B/C) (Link)
 
* Dosing Information
 
:: (Dosage)
 
====Non–Guideline-Supported Use====
 
=====Condition 1=====
 
* Dosing Information
 
:: (Dosage)
 
=====Condition 2=====
 
* Dosing Information
 
:: (Dosage)
 
=====Condition 3=====
 
* Dosing Information
 
:: (Dosage)
 
==Contraindications==
 
* Condition 1
* Condition 2
* Condition 3
* Condition 4
* Condition 5
 
==Warnings==
 
=====Conidition 1=====
 
(Description)
 
=====Conidition 2=====
 
(Description)
 
=====Conidition 3=====
 
(Description)
 
==Adverse Reactions==
 
===Clinical Trials Experience===
 
=====Condition 1=====
 
======Central Nervous System======
 
: (list/description of adverse reactions)
 
======Cardiovascular======
 
: (list/description of adverse reactions)
 
======Respiratory======
 
: (list/description of adverse reactions)
 
======Gastrointestinal======
 
: (list/description of adverse reactions)
 
======Hypersensitive Reactions======
 
: (list/description of adverse reactions)
 
======Miscellaneous======
 
: (list/description of adverse reactions)
 
=====Condition 1=====
 
======Central Nervous System======
 
: (list/description of adverse reactions)
 
======Cardiovascular======
 
: (list/description of adverse reactions)
 
======Respiratory======
 
: (list/description of adverse reactions)
 
======Gastrointestinal======
 
: (list/description of adverse reactions)
 
======Hypersensitive Reactions======
 
: (list/description of adverse reactions)
 
======Miscellaneous======
 
: (list/description of adverse reactions)
 
===Postmarketing Experience===
 
(Description)
 
==Drug Interactions==
 
* Drug 1
* Drug 2
* Drug 3
* Drug 4
* Drug 5
 
=====Drug 1=====
 
(Description)
 
=====Drug 2=====
 
(Description)
 
=====Drug 3=====
 
(Description)
 
=====Drug 4=====
 
(Description)
 
=====Drug 5=====
 
(Description)
 
==Use in Specific Populations==
 
====Pregnancy====
 
: '''[[Pregnancy category#United States|Pregnancy Category (FDA)]]: X'''
 
: '''[[Pregnancy category#Australia|Pregnancy Category (AUS)]]: X'''
 
(Description)
 
====Labor and Delivery====
 
(Description)
 
====Nursing Mothers====
 
(Description)
 
====Pediatric Use====
 
(Description)
 
====Geriatric Use====
 
(Description)
 
====Gender====
 
(Description)
 
====Race====
 
(Description)
 
====Renal Impairment====
 
(Description)
 
====Hepatic Impairment====
 
(Description)
 
====Females of Reproductive Potential and Males====
 
(Description)
 
====Immunocompromised Patients====
 
(Description)
 
==Administration and Monitoring==
 
====Administration====
 
(Oral/Intravenous/etc)
 
====Monitoring====
 
=====Condition 1=====
 
(Description regarding monitoring, from ''Warnings'' section)
 
=====Condition 2=====
 
(Description regarding monitoring, from ''Warnings'' section)
 
=====Condition 3=====
 
(Description regarding monitoring, from ''Warnings'' section)
 
==IV Compatibility==
 
===Solution===
 
====Compatible====
 
* Solution 1
* Solution 2
* Solution 3
 
====Not Tested====
 
* Solution 1
* Solution 2
* Solution 3
 
====Variable====
 
* Solution 1
* Solution 2
* Solution 3
 
====Incompatible====
 
* Solution 1
* Solution 2
* Solution 3
 
===Y-Site===
 
====Compatible====
 
* Solution 1
* Solution 2
* Solution 3
 
====Not Tested====
 
* Solution 1
* Solution 2
* Solution 3
 
====Variable====
 
* Solution 1
* Solution 2
* Solution 3


==[[{{BASEPAGENAME}}/adult indications and dosage|Adult Indications and Dosage]]==
====Incompatible====


: <BIG><BIG>'''[[{{BASEPAGENAME}}/adult indications and dosage#FDA-Labeled Indications and Dosage (Adult)|FDA-Labeled Indications and Dosage (Adult)]]'''</BIG></BIG>
* Solution 1
* Solution 2
* Solution 3


: <BIG><BIG>'''[[{{BASEPAGENAME}}/adult indications and dosage#Off-Label Use and Dosage (Adult)|Off-Label Use and Dosage (Adult)]]'''</BIG></BIG>
===Admixture===


==[[{{BASEPAGENAME}}/pediatric indications and dosage|Pediatric Indications and Dosag]]e==
====Compatible====


: <BIG><BIG>'''[[{{BASEPAGENAME}}/pediatric indications and dosage#FDA-Labeled Indications and Dosage (Pediatric)|FDA-Labeled Indications and Dosage (Pediatric)]]'''</BIG></BIG>
* Solution 1
* Solution 2
* Solution 3


: <BIG><BIG>'''[[{{BASEPAGENAME}}/pediatric indications and dosage#Off-Label Use and Dosage (Pediatric)|Off-Label Use and Dosage (Pediatric)]]'''</BIG></BIG>
====Not Tested====


==[[{{BASEPAGENAME}}/contraindications|Contraindications]]==
* Solution 1
* Solution 2
* Solution 3


==[[{{BASEPAGENAME}}/warnings|Warnings]]==
====Variable====


==[[{{BASEPAGENAME}}/adverse reactions|Adverse Reactions]]==
* Solution 1
* Solution 2
* Solution 3


: <BIG><BIG>'''[[{{BASEPAGENAME}}/adverse reactions#Clinical Trials Experience|Clinical Trials Experience]]'''</BIG></BIG>
====Incompatible====


: <BIG><BIG>'''[[{{BASEPAGENAME}}/adverse reactions#Postmarketing Experience|Postmarketing Experience]]'''</BIG></BIG>
* Solution 1
* Solution 2
* Solution 3


==[[{{BASEPAGENAME}}/drug interactions|Drug Interactions]]==
===Syringe===


==[[{{BASEPAGENAME}}/use in specific populations|Use in Specific Populations]]==
====Compatible====


: <BIG><BIG>'''[[{{BASEPAGENAME}}/use in specific populations#Pregnancy|Pregnancy]]'''</BIG></BIG>
* Solution 1
* Solution 2
* Solution 3


: <BIG><BIG>'''[[{{BASEPAGENAME}}/use in specific populations#Labor and Delivery|Labor and Delivery]]'''</BIG></BIG>
====Not Tested====


: <BIG><BIG>'''[[{{BASEPAGENAME}}/use in specific populations#Nursing Mothers|Nursing Mothers]]'''</BIG></BIG>
* Solution 1
* Solution 2
* Solution 3


: <BIG><BIG>'''[[{{BASEPAGENAME}}/use in specific populations#Pediatric Use|Pediatric Use]]'''</BIG></BIG>
====Variable====


: <BIG><BIG>'''[[{{BASEPAGENAME}}/use in specific populations#Geriatric Use|Geriatric Use]]'''</BIG></BIG>
* Solution 1
* Solution 2
* Solution 3


: <BIG><BIG>'''[[{{BASEPAGENAME}}/use in specific populations#Gender|Gender]]'''</BIG></BIG>
====Incompatible====


: <BIG><BIG>'''[[{{BASEPAGENAME}}/use in specific populations#Race|Race]]'''</BIG></BIG>
* Solution 1
* Solution 2
* Solution 3


: <BIG><BIG>'''[[{{BASEPAGENAME}}/use in specific populations#Renal Impairment|Renal Impairment]]'''</BIG></BIG>
===TPN/TNA===


: <BIG><BIG>'''[[{{BASEPAGENAME}}/use in specific populations#Hepatic Impairment|Hepatic Impairment]]'''</BIG></BIG>
====Compatible====


: <BIG><BIG>'''[[{{BASEPAGENAME}}/use in specific populations#Females of Reproductive Potential and Males|Females of Reproductive Potential and Males]]'''</BIG></BIG>
* Solution 1
* Solution 2
* Solution 3


: <BIG><BIG>'''[[{{BASEPAGENAME}}/use in specific populations#Immunocompromised Patients|Immunocompromised Patients]]'''</BIG></BIG>
====Not Tested====


==[[{{BASEPAGENAME}}/routes and preparations|Routes and Preparations]]==
* Solution 1
* Solution 2
* Solution 3


==[[{{BASEPAGENAME}}/IV compatibility|IV Compatibility]]==
====Variable====


==[[{{BASEPAGENAME}}/overdosage|Overdosage]]==
* Solution 1
* Solution 2
* Solution 3


==[[{{BASEPAGENAME}}/pharmacology|Pharmacology]]==
====Incompatible====


: <BIG><BIG>'''[[{{BASEPAGENAME}}/pharmacology#Mechanism of Action|Mechanism of Action]]'''</BIG></BIG>
* Solution 1
* Solution 2
* Solution 3


: <BIG><BIG>'''[[{{BASEPAGENAME}}/pharmacology#Structure|Structure]]'''</BIG></BIG>
==Overdosage==


: <BIG><BIG>'''[[{{BASEPAGENAME}}/pharmacology#Pharmacodynamics|Pharmacodynamics]]'''</BIG></BIG>
===Acute Overdose===


: <BIG><BIG>'''[[{{BASEPAGENAME}}/pharmacology#Pharmacokinetics|Pharmacokinetics]]'''</BIG></BIG>
====Signs and Symptoms====


: <BIG><BIG>'''[[{{BASEPAGENAME}}/pharmacology#Nonclinical Toxicology|Nonclinical Toxicology]]'''</BIG></BIG>
(Description)


==[[{{BASEPAGENAME}}/clinical studies|Clinical Studies]]==
====Management====


==[[{{BASEPAGENAME}}/how supplied|How Supplied]]==
(Description)


==[[{{BASEPAGENAME}}/images|Images]]==
===Chronic Overdose===


: <BIG><BIG>'''[[{{BASEPAGENAME}}/images#Drug Images|Drug Images]]'''</BIG></BIG>
====Signs and Symptoms====


: <BIG><BIG>'''[[{{BASEPAGENAME}}/images#Package and Label Display Panel|Package and Label Display Panel]]'''</BIG></BIG>
(Description)


==[[{{BASEPAGENAME}}/patient information|Patient Information]]==
====Management====


: <BIG><BIG>'''[[{{BASEPAGENAME}}/patient information#Patient Information from FDA|Patient Information from FDA]]'''</BIG></BIG>
(Description)


: <BIG><BIG>'''[[{{BASEPAGENAME}}/patient information#Patient Information from NLM|Patient Information from NLM]]'''</BIG></BIG>
==Pharmacology==


==Taking with Alcohol==
{{Drugbox2
| verifiedrevid =  
| IUPAC_name =  
| image =  
| drug_name =  


Alcohol-{{BASEPAGENAME}} interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
<!--Clinical data-->
| tradename =
| MedlinePlus =
| licence_US =
| pregnancy_AU =
| pregnancy_US =
| legal_status =
| routes_of_administration =
 
<!--Pharmacokinetic data-->
| bioavailability =
| metabolism =
| elimination_half-life =
| excretion =
 
<!--Identifiers-->
| CAS_number_Ref =
| CAS_number =
| ATC_prefix =
| ATC_suffix =
| PubChem =
| IUPHAR_ligand =
| DrugBank_Ref =
| DrugBank =
| ChemSpiderID_Ref =
| ChemSpiderID =
| UNII_Ref =
| UNII =
| KEGG_Ref =
| KEGG =
| ChEBI_Ref =
| ChEBI =
| ChEMBL_Ref =
| ChEMBL =
 
<!--Chemical data-->
| C= | H= | N= | O=
| molecular_weight =
| smiles =
| InChI =
| InChIKey =
| StdInChI_Ref =
| StdInChI =
| StdInChIKey_Ref =
| StdInChIKey =
| melting_point =
}}
 
===Mechanism of Action===
 
(Description)
 
===Structure===
 
(Description with picture)
 
===Pharmacodynamics===
 
(Description)
 
===Pharmacokinetics===
 
(Description)
 
===Nonclinical Toxicology===
 
(Description)
 
==Clinical Studies==
 
=====Condition 1=====
 
(Description)
 
=====Condition 2=====
 
(Description)
 
=====Condition 3=====
 
(Description)
 
==How Supplied==
 
(Description)
 
* National Drug Code (NDC):
* Storage:
* Manufactured by: 
* Distributed by:
 
==Images==
 
===Drug Images===
 
(PillBox Images)
 
===Package and Label Display Panel===
 
(Package Images)
 
(Display Panel Images)
 
==Patient Information==
 
===Patient Information from FDA===
 
(Patient Counseling Information)
 
===Patient Information from NLM===
 
(Link to patient information page)
 
==Precautions with Alcohol==
 
Alcohol-{{PAGENAME}} interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.


==Look-Alike Drug Names==
==Look-Alike Drug Names==


* (Paired Confused Name 1a) — (Paired Confused Name 1b)
* (Paired Confused Name 2a) — (Paired Confused Name 2b)
* (Paired Confused Name 3a) — (Paired Confused Name 3b)


==[http://www.fda.gov/drugs/drugsafety/drugshortages/ucm050792.htm Drug Shortage Status]==


==[http://www.fda.gov/drugs/drugsafety/drugshortages/ucm050792.htm Drug Shortage Status]==
==[http://www.goodrx.com/{{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}/price Price]==
 
==References==
 
{{reflist}}
 
</div>
 
==Overview==


==[http://www.goodrx.com/{{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{BASEPAGENAME}}}}}}/price Price]==
{{PAGENAME}} is a anti-anginal, antiarrhythmic, beta-adrenergic blocker drug that is FDA approved for the treatment of [[acute myocardial infarction]]. Common adverse reactions include [[bradyarrhythmia]], [[heart block]], [[heart failure]], [[hypotension]], [[pruritus]], [[rash]], [[constipation]], [[diarrhea]], [[indigestion]], [[nausea]], [[dizziness]], [[fatigue]], [[headache]], [[depression]], [[dyspnea]], and [[wheezing]].

Revision as of 21:19, 21 March 2014

Lopressor injection®
Black Box Warning
Adult Indications and Dosage
Pediatric Indications and Dosage
Contraindications
Warnings
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration and Monitoring
IV Compatibility
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient information
Precautions with Alcohol
Look-Alike Drug Names
Drug Shortage Status
Price

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

For information about metoprolol, click here.

Disclaimer

(Disclaimer here)

Black Box Warning

FDA Package Insert for Lopressor injection contains no information regarding Black Box Warning.

Overview

Lopressor injection is a _______ drug that is FDA approved for the treatment of _______. There is a Black Box Warning for this drug as shown here. Common adverse reactions include _______.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

Condition 1
  • Dosing Information
(Dosage)
Condition 2
  • Dosing Information
(Dosage)

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

Condition 1
  • Developed by: (Organisation)
  • Class of Recommendation: (Class) (Link)
  • Strength of Evidence: (Category A/B/C) (Link)
  • Dosing Information
(Dosage)
Condition 2
  • Developed by: (Organisation)
  • Class of Recommendation: (Class) (Link)
  • Strength of Evidence: (Category A/B/C) (Link)
  • Dosing Information
(Dosage)

Non–Guideline-Supported Use

Condition 1
  • Dosing Information
(Dosage)
Condition 2
  • Dosing Information
(Dosage)
Condition 3
  • Dosing Information
(Dosage)

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

Condition 1
  • Dosing Information
(Dosage)
Condition 2
  • Dosing Information
(Dosage)

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

Condition 1
  • Developed by: (Organisation)
  • Class of Recommendation: (Class) (Link)
  • Strength of Evidence: (Category A/B/C) (Link)
  • Dosing Information
(Dosage)
Condition 2
  • Developed by: (Organisation)
  • Class of Recommendation: (Class) (Link)
  • Strength of Evidence: (Category A/B/C) (Link)
  • Dosing Information
(Dosage)

Non–Guideline-Supported Use

Condition 1
  • Dosing Information
(Dosage)
Condition 2
  • Dosing Information
(Dosage)
Condition 3
  • Dosing Information
(Dosage)

Contraindications

  • Condition 1
  • Condition 2
  • Condition 3
  • Condition 4
  • Condition 5

Warnings

Conidition 1

(Description)

Conidition 2

(Description)

Conidition 3

(Description)

Adverse Reactions

Clinical Trials Experience

Condition 1
Central Nervous System
(list/description of adverse reactions)
Cardiovascular
(list/description of adverse reactions)
Respiratory
(list/description of adverse reactions)
Gastrointestinal
(list/description of adverse reactions)
Hypersensitive Reactions
(list/description of adverse reactions)
Miscellaneous
(list/description of adverse reactions)
Condition 1
Central Nervous System
(list/description of adverse reactions)
Cardiovascular
(list/description of adverse reactions)
Respiratory
(list/description of adverse reactions)
Gastrointestinal
(list/description of adverse reactions)
Hypersensitive Reactions
(list/description of adverse reactions)
Miscellaneous
(list/description of adverse reactions)

Postmarketing Experience

(Description)

Drug Interactions

  • Drug 1
  • Drug 2
  • Drug 3
  • Drug 4
  • Drug 5
Drug 1

(Description)

Drug 2

(Description)

Drug 3

(Description)

Drug 4

(Description)

Drug 5

(Description)

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA): X
Pregnancy Category (AUS): X

(Description)

Labor and Delivery

(Description)

Nursing Mothers

(Description)

Pediatric Use

(Description)

Geriatric Use

(Description)

Gender

(Description)

Race

(Description)

Renal Impairment

(Description)

Hepatic Impairment

(Description)

Females of Reproductive Potential and Males

(Description)

Immunocompromised Patients

(Description)

Administration and Monitoring

Administration

(Oral/Intravenous/etc)

Monitoring

Condition 1

(Description regarding monitoring, from Warnings section)

Condition 2

(Description regarding monitoring, from Warnings section)

Condition 3

(Description regarding monitoring, from Warnings section)

IV Compatibility

Solution

Compatible

  • Solution 1
  • Solution 2
  • Solution 3

Not Tested

  • Solution 1
  • Solution 2
  • Solution 3

Variable

  • Solution 1
  • Solution 2
  • Solution 3

Incompatible

  • Solution 1
  • Solution 2
  • Solution 3

Y-Site

Compatible

  • Solution 1
  • Solution 2
  • Solution 3

Not Tested

  • Solution 1
  • Solution 2
  • Solution 3

Variable

  • Solution 1
  • Solution 2
  • Solution 3

Incompatible

  • Solution 1
  • Solution 2
  • Solution 3

Admixture

Compatible

  • Solution 1
  • Solution 2
  • Solution 3

Not Tested

  • Solution 1
  • Solution 2
  • Solution 3

Variable

  • Solution 1
  • Solution 2
  • Solution 3

Incompatible

  • Solution 1
  • Solution 2
  • Solution 3

Syringe

Compatible

  • Solution 1
  • Solution 2
  • Solution 3

Not Tested

  • Solution 1
  • Solution 2
  • Solution 3

Variable

  • Solution 1
  • Solution 2
  • Solution 3

Incompatible

  • Solution 1
  • Solution 2
  • Solution 3

TPN/TNA

Compatible

  • Solution 1
  • Solution 2
  • Solution 3

Not Tested

  • Solution 1
  • Solution 2
  • Solution 3

Variable

  • Solution 1
  • Solution 2
  • Solution 3

Incompatible

  • Solution 1
  • Solution 2
  • Solution 3

Overdosage

Acute Overdose

Signs and Symptoms

(Description)

Management

(Description)

Chronic Overdose

Signs and Symptoms

(Description)

Management

(Description)

Pharmacology

Chemical structure of Lopressor injection
Lopressor injection
Systematic (IUPAC) name
?
Identifiers
CAS number ?
ATC code ?
PubChem ?
Chemical data
Formula ?
Mol. mass ?
Pharmacokinetic data
Bioavailability ?
Metabolism ?
Half life ?
Excretion ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes ?

Mechanism of Action

(Description)

Structure

(Description with picture)

Pharmacodynamics

(Description)

Pharmacokinetics

(Description)

Nonclinical Toxicology

(Description)

Clinical Studies

Condition 1

(Description)

Condition 2

(Description)

Condition 3

(Description)

How Supplied

(Description)

  • National Drug Code (NDC):
  • Storage:
  • Manufactured by:
  • Distributed by:

Images

Drug Images

(PillBox Images)

Package and Label Display Panel

(Package Images)

(Display Panel Images)

Patient Information

Patient Information from FDA

(Patient Counseling Information)

Patient Information from NLM

(Link to patient information page)

Precautions with Alcohol

Alcohol-Lopressor injection interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Look-Alike Drug Names

  • (Paired Confused Name 1a) — (Paired Confused Name 1b)
  • (Paired Confused Name 2a) — (Paired Confused Name 2b)
  • (Paired Confused Name 3a) — (Paired Confused Name 3b)

Drug Shortage Status

Price

References

Overview

Lopressor injection is a anti-anginal, antiarrhythmic, beta-adrenergic blocker drug that is FDA approved for the treatment of acute myocardial infarction. Common adverse reactions include bradyarrhythmia, heart block, heart failure, hypotension, pruritus, rash, constipation, diarrhea, indigestion, nausea, dizziness, fatigue, headache, depression, dyspnea, and wheezing.

Retrieved from "https://www.wikidoc.org/index.php?title=Lopressor_injection&oldid=958963"